Healthcare Global Enterprises Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2026 ,inter alia, to consider and approve This is to inform ....
HCG · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
HealthCare Global Enterprises has informed the stock exchanges that its Board of Directors will meet on Thursday, February 5, 2026, at its Bengaluru corporate office. The main agenda is to consider, approve, and take on record the unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025 (Q3 FY26). The trading window for designated persons is already closed since January 1, 2026, and will remain shut until 48 hours after the results are declared. The filing is a standard regulatory intimation under SEBI LODR Regulation 29.
Investors should watch for the Q3 FY26 results on or shortly after February 5, 2026 — any meaningful surprise in revenue, margins, or profitability could move the stock. Until then, the trading window closure limits insider activity.